399 related articles for article (PubMed ID: 32566095)
1. Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing.
Ma Z; Xu L; Liu D; Zhang X; Di S; Li W; Zhang J; Reiter RJ; Han J; Li X; Yan X
Oxid Med Cell Longev; 2020; 2020():6841581. PubMed ID: 32566095
[TBL] [Abstract][Full Text] [Related]
2. Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.
Jang H; Hong K; Choi Y
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590419
[TBL] [Abstract][Full Text] [Related]
3. A review of the protective role of melatonin during phosphine-induced cardiotoxicity: focus on mitochondrial dysfunction, oxidative stress and apoptosis.
Asghari MH; Abdollahi M; de Oliveira MR; Nabavi SM
J Pharm Pharmacol; 2017 Mar; 69(3):236-243. PubMed ID: 28000313
[TBL] [Abstract][Full Text] [Related]
4. Protective Effects of Melatonin on Neurogenesis Impairment in Neurological Disorders and Its Relevant Molecular Mechanisms.
Leung JW; Cheung KK; Ngai SP; Tsang HW; Lau BW
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781737
[TBL] [Abstract][Full Text] [Related]
5. A review of melatonin in hepatic ischemia/reperfusion injury and clinical liver disease.
Li Y; Yang Y; Feng Y; Yan J; Fan C; Jiang S; Qu Y
Ann Med; 2014 Nov; 46(7):503-11. PubMed ID: 25033992
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin.
Govender J; Loos B; Marais E; Engelbrecht AM
J Pineal Res; 2014 Nov; 57(4):367-80. PubMed ID: 25230823
[TBL] [Abstract][Full Text] [Related]
7. Melatonin: does it have utility in the treatment of haematological neoplasms?
Li T; Yang Z; Jiang S; Di W; Ma Z; Hu W; Chen F; Reiter RJ; Yang Y
Br J Pharmacol; 2018 Aug; 175(16):3251-3262. PubMed ID: 28880375
[TBL] [Abstract][Full Text] [Related]
8. Melatonin as an adjuvant treatment modality with doxorubicin.
Maleki Dana P; Sadoughi F; Reiter RJ; Mohammadi S; Heidar Z; Mirzamoradi M; Asemi Z
Biochimie; 2022 Nov; 202():49-55. PubMed ID: 35752222
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin.
Lissoni P; Tancini G; Barni S; Paolorossi F; Ardizzoia A; Conti A; Maestroni G
Support Care Cancer; 1997 Mar; 5(2):126-9. PubMed ID: 9069612
[TBL] [Abstract][Full Text] [Related]
10. Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review.
Mortezaee K; Najafi M; Farhood B; Ahmadi A; Potes Y; Shabeeb D; Musa AE
Life Sci; 2019 Jul; 228():228-241. PubMed ID: 31077716
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy with melatonin for targeting human cancers: A review.
Najafi M; Salehi E; Farhood B; Nashtaei MS; Hashemi Goradel N; Khanlarkhani N; Namjoo Z; Mortezaee K
J Cell Physiol; 2019 Mar; 234(3):2356-2372. PubMed ID: 30192001
[TBL] [Abstract][Full Text] [Related]
12. Melatonin as a treatment for gastrointestinal cancer: a review.
Xin Z; Jiang S; Jiang P; Yan X; Fan C; Di S; Wu G; Yang Y; Reiter RJ; Ji G
J Pineal Res; 2015 May; 58(4):375-87. PubMed ID: 25752643
[TBL] [Abstract][Full Text] [Related]
13. Melatonin in cancer management: progress and promise.
Jung B; Ahmad N
Cancer Res; 2006 Oct; 66(20):9789-93. PubMed ID: 17047036
[TBL] [Abstract][Full Text] [Related]
14. Melatonin Enhances Cisplatin and Radiation Cytotoxicity in Head and Neck Squamous Cell Carcinoma by Stimulating Mitochondrial ROS Generation, Apoptosis, and Autophagy.
Fernandez-Gil BI; Guerra-Librero A; Shen YQ; Florido J; Martínez-Ruiz L; García-López S; Adan C; Rodríguez-Santana C; Acuña-Castroviejo D; Quiñones-Hinojosa A; Fernández-Martínez J; Abdel Moneim AE; López LC; Rodríguez Ferrer JM; Escames G
Oxid Med Cell Longev; 2019; 2019():7187128. PubMed ID: 30944696
[TBL] [Abstract][Full Text] [Related]
15. Melatonin and cisplatin co-treatment against cancer: A mechanistic review of their synergistic effects and melatonin's protective actions.
Rafiyan M; Davoodvandi A; Reiter RJ; Mansournia MA; Rasooli Manesh SM; Arabshahi V; Asemi Z
Pathol Res Pract; 2024 Jan; 253():155031. PubMed ID: 38103362
[TBL] [Abstract][Full Text] [Related]
16. Melatonin as a potential inhibitor of kidney cancer: A survey of the molecular processes.
Maleki Dana P; Reiter RJ; Hallajzadeh J; Asemi Z; Mansournia MA; Yousefi B
IUBMB Life; 2020 Nov; 72(11):2355-2365. PubMed ID: 32918860
[TBL] [Abstract][Full Text] [Related]
17. The role of melatonin, a multitasking molecule, in retarding the processes of ageing.
Majidinia M; Reiter RJ; Shakouri SK; Yousefi B
Ageing Res Rev; 2018 Nov; 47():198-213. PubMed ID: 30092361
[TBL] [Abstract][Full Text] [Related]
18. Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice.
Toyama S; Shimoyama N; Szeto HH; Schiller PW; Shimoyama M
ACS Chem Neurosci; 2018 Jul; 9(7):1566-1571. PubMed ID: 29660270
[TBL] [Abstract][Full Text] [Related]
19. Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer.
Wojcik M; Krawczyk M; Wojcik P; Cypryk K; Wozniak LA
Curr Med Chem; 2017 Nov; 24(35):3829-3850. PubMed ID: 28721827
[TBL] [Abstract][Full Text] [Related]
20. Cytoprotective Agents to Avoid Chemotherapy Induced Sideeffects on Normal Cells: A Review.
Rohilla S; Dureja H; Chawla V
Curr Cancer Drug Targets; 2019; 19(10):765-781. PubMed ID: 30914026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
